Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FN3ZT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,140
Award facts
- Contract value 100% obligated
- $35,139.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $35,139.97 to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 10 mg/0.5 mL pens on August 25, 2025. This firm fixed-price contract, which represents a non-competitive set-aside, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 26, 2025. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical supply vehicle running through December 2026 that enables the company to furnish a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The contractor's federal contract portfolio demonstrates extensive capability in delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This specific delivery order for Zepbound supports the broader pharmaceutical supply chain needs of the Department of Defense, consistent with DLA's mission to provide medical supplies to military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FN3ZT?
SPE2DB25FN3ZT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 25, 2025.
How much is contract SPE2DB25FN3ZT worth?
The government has obligated $35,140 on SPE2DB25FN3ZT.
Is contract SPE2DB25FN3ZT an order under another contract?
Yes. SPE2DB25FN3ZT is a delivery order under SPE2DB22D1200, an indefinite delivery contract.
Was contract SPE2DB25FN3ZT competed?
The extent of competition for SPE2DB25FN3ZT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award